Concepedia

Christopher Yea

CY

15

Publications

810

Citations

14

H-Index

1990

Active since

Affiliations

KalVista Pharmaceuticals (United States)(Current)

Goethe University Frankfurt

Humboldt-Universität zu Berlin

University of Toronto

University of California San Diego

Christopher Yea is an author at KalVista Pharmaceuticals (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1990–2024

15

Publications

15

Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound

Richard A. Williamson, Christopher Yea, P.A. Robson et al. · Journal of Biological Chemistry · 1995 · 196 citations · Full text

Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide

Jean‐Michel Bruneau, Christopher Yea, Sylviane Spinella-Jaegle et al. · Biochemical Journal · 1998 · 146 citations · Full text

Synthesis, Structure−Activity Relationships, and Pharmacokinetic Properties of Dihydroorotate Dehydrogenase Inhibitors:  2-Cyano-3-cyclopropyl-3-hydroxy- <i>N</i>-[3‘-methyl-4‘-(trifluoromethyl)phenyl]propenamide and Related Compounds

Elizabeth Kuo, P. Hambleton, David P. Kay et al. · Journal of Medicinal Chemistry · 1996 · 90 citations · Full text

, , +19

Purification and some properties of the 45 kDa diphenylene iodonium-binding flavoprotein of neutrophil NADPH oxidase

Christopher Yea, Andrew R. Cross, Owen Jones · Biochemical Journal · 1990 · 62 citations · Full text

Rapid Suppression of Plasma Testosterone Levels and Tumor Growth in the Dunning Rat Model Treated with Degarelix, a New Gonadotropin-Releasing Hormone Antagonist

M Princivalle, Pierre Broqua, Richard White et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 56 citations

Rows per page

1–5 of 15